GL1X · GenesisL1 explorer

MolNFT v1 · #106314 · protein

Crystal structure of multidrug-resistant clinical isolate A02 HIV-1 protease in complex with amprenavir

4RVJ: “Crystal structure of multidrug-resistant clinical isolate A02 HIV-1 protease in complex with amprenavir”. X-ray diffraction, 1 ligand (478), 2 pockets (best druggability 0.73). MolNFT v1 #106314 on GenesisL1: 3D structure, binding…

PDB
4RVJ
Type
protein
Length
396 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
HIV-1 protease
UniProt
Q9J006
Ligands
478
Pockets
2 · best druggability 0.73

Structure

x-ray diffraction · 1 distinct chain · 7% helix, 58% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, B, C, DHIV-1 proteaseprotein997% helix, 58% strandQ9J006

Ligands and binding sites

  • 478 · {3-[(4-amino-benzenesulfonyl)-isobutyl-amino]-1-benzyl-2-hydroxy-propyl}-carbamic acid tetrahydro-furan-3-yl ester · ligand · 2 copies · chains A, B, C, D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13730.730.8440478
23790.720.8341478

Interfaces

5 interfaces between chains.

  • A–B · 1876 Ų buried · 34 hydrogen bonds · protein-protein
  • C–D · 1862 Ų buried · 33 hydrogen bonds · protein-protein
  • B–C · 20 Ų buried · 0 hydrogen bonds · protein-protein
  • A–D · 19 Ų buried · 0 hydrogen bonds · protein-protein
  • A–C · 15 Ų buried · 0 hydrogen bonds · protein-protein

Compared structures

  • 4RVJ · Crystal structure of multidrug-resistant clinical isolate A02 HIV-1 protease in complex… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.